Douglas Jermasek
Corporate Officer/Principal at UNICYCIVE THERAPEUTICS, INC.
Net worth: 169 762 $ as of 30/04/2024
Douglas Jermasek active positions
| Companies | Position | Start | End |
|---|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Corporate Officer/Principal | 26/10/2021 | - |
Career history of Douglas Jermasek
Former positions of Douglas Jermasek
| Companies | Position | Start | End |
|---|---|---|---|
| KERYX BIOPHARMACEUTICALS | Sales & Marketing | 01/07/2016 | 12/12/2018 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
| AKEBIA THERAPEUTICS, INC. | Sales & Marketing | - | - |
Deltanoid Pharmaceuticals, Inc.
 Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI. | Chief Executive Officer | 02/02/2016 | - |
Training of Douglas Jermasek
| BYU Marriott School | Masters Business Admin |
| Brigham Young University | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Health Technology |
| AKEBIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Deltanoid Pharmaceuticals, Inc.
Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI. | Commercial Services |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Douglas Jermasek
- Experience
